Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.
Gouzien L, Che D, Cassaing S, Lortholary O, Letscher-Bru V, Paccoud O, Obadia T, Morio F, Moniot M, Cateau E, Bougnoux ME, Chouaki T, Hasseine L, Desoubeaux G, Gautier C, Mahinc-Martin C, Huguenin A, Bonhomme J, Sitbon K, Durand J, Alanio A, Millon L, Garcia-Hermoso D, Lanternier F; French Mycoses Study Group.
Gouzien L, et al.
Lancet Reg Health Eur. 2024 Aug 7;45:101010. doi: 10.1016/j.lanepe.2024.101010. eCollection 2024 Oct.
Lancet Reg Health Eur. 2024.
PMID: 39220434
Free PMC article.